Prevalence and impact of migraine

Richard B. Lipton, W. F. Stewart

Research output: Contribution to journalArticle

131 Citations (Scopus)

Abstract

Knowledge of the epidemiology of migraine has expanded because of the recent proliferation of large scale population-based studies using standardized case definitions. Migraine is a highly prevalent disorder, affecting about 6% of men and 15% to 18% of women. Migraine prevalence is highest between the ages of 25 and 55 years, accounting for its enormous impact in the workplace. Migraine imposes a substantial burden on society as measured by direct and indirect costs. Because the indirect costs greatly exceed the direct costs and because migraine is underdiagnosed and undertreated, improvements in treatment should reduce individual suffering and reduce work loss in a cost-effective manner.

Original languageEnglish (US)
Pages (from-to)1-13
Number of pages13
JournalNeurologic Clinics
Volume15
Issue number1
DOIs
StatePublished - 1997

Fingerprint

Migraine Disorders
Costs and Cost Analysis
Psychological Stress
Workplace
Epidemiology
Population
Therapeutics

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Prevalence and impact of migraine. / Lipton, Richard B.; Stewart, W. F.

In: Neurologic Clinics, Vol. 15, No. 1, 1997, p. 1-13.

Research output: Contribution to journalArticle

Lipton, Richard B. ; Stewart, W. F. / Prevalence and impact of migraine. In: Neurologic Clinics. 1997 ; Vol. 15, No. 1. pp. 1-13.
@article{e8df36a51eb343e5a61ec9c5d4687199,
title = "Prevalence and impact of migraine",
abstract = "Knowledge of the epidemiology of migraine has expanded because of the recent proliferation of large scale population-based studies using standardized case definitions. Migraine is a highly prevalent disorder, affecting about 6{\%} of men and 15{\%} to 18{\%} of women. Migraine prevalence is highest between the ages of 25 and 55 years, accounting for its enormous impact in the workplace. Migraine imposes a substantial burden on society as measured by direct and indirect costs. Because the indirect costs greatly exceed the direct costs and because migraine is underdiagnosed and undertreated, improvements in treatment should reduce individual suffering and reduce work loss in a cost-effective manner.",
author = "Lipton, {Richard B.} and Stewart, {W. F.}",
year = "1997",
doi = "10.1016/S0733-8619(05)70291-7",
language = "English (US)",
volume = "15",
pages = "1--13",
journal = "Neurologic Clinics",
issn = "0733-8619",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Prevalence and impact of migraine

AU - Lipton, Richard B.

AU - Stewart, W. F.

PY - 1997

Y1 - 1997

N2 - Knowledge of the epidemiology of migraine has expanded because of the recent proliferation of large scale population-based studies using standardized case definitions. Migraine is a highly prevalent disorder, affecting about 6% of men and 15% to 18% of women. Migraine prevalence is highest between the ages of 25 and 55 years, accounting for its enormous impact in the workplace. Migraine imposes a substantial burden on society as measured by direct and indirect costs. Because the indirect costs greatly exceed the direct costs and because migraine is underdiagnosed and undertreated, improvements in treatment should reduce individual suffering and reduce work loss in a cost-effective manner.

AB - Knowledge of the epidemiology of migraine has expanded because of the recent proliferation of large scale population-based studies using standardized case definitions. Migraine is a highly prevalent disorder, affecting about 6% of men and 15% to 18% of women. Migraine prevalence is highest between the ages of 25 and 55 years, accounting for its enormous impact in the workplace. Migraine imposes a substantial burden on society as measured by direct and indirect costs. Because the indirect costs greatly exceed the direct costs and because migraine is underdiagnosed and undertreated, improvements in treatment should reduce individual suffering and reduce work loss in a cost-effective manner.

UR - http://www.scopus.com/inward/record.url?scp=0031019151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031019151&partnerID=8YFLogxK

U2 - 10.1016/S0733-8619(05)70291-7

DO - 10.1016/S0733-8619(05)70291-7

M3 - Article

C2 - 9058393

AN - SCOPUS:0031019151

VL - 15

SP - 1

EP - 13

JO - Neurologic Clinics

JF - Neurologic Clinics

SN - 0733-8619

IS - 1

ER -